The Beauty Health Company (NASDAQ:SKIN) Shares Purchased by SG Americas Securities LLC

SG Americas Securities LLC increased its stake in shares of The Beauty Health Company (NASDAQ:SKIN) by 35.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 39,630 shares of the company’s stock after acquiring an additional 10,332 shares during the period. SG Americas Securities LLC’s holdings in Beauty Health were worth $123,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Tower Research Capital LLC TRC grew its holdings in Beauty Health by 172.2% in the second quarter. Tower Research Capital LLC TRC now owns 6,666 shares of the company’s stock valued at $56,000 after purchasing an additional 4,217 shares during the period. State of Wyoming increased its stake in Beauty Health by 46.4% during the fourth quarter. State of Wyoming now owns 6,791 shares of the company’s stock worth $62,000 after acquiring an additional 2,152 shares during the last quarter. Royal Bank of Canada increased its stake in Beauty Health by 22.8% during the third quarter. Royal Bank of Canada now owns 7,700 shares of the company’s stock worth $91,000 after acquiring an additional 1,430 shares during the last quarter. Amundi increased its stake in Beauty Health by 24.1% during the fourth quarter. Amundi now owns 9,032 shares of the company’s stock worth $92,000 after acquiring an additional 1,754 shares during the last quarter. Finally, Boothbay Fund Management LLC acquired a new stake in shares of Beauty Health in the first quarter valued at $128,000. 93.26% of the stock is owned by institutional investors and hedge funds.

Beauty Health Stock Performance

SKIN opened at $3.43 on Friday. The stock has a market cap of $423.36 million, a P/E ratio of -4.45 and a beta of 1.01. The company has a debt-to-equity ratio of 12.43, a current ratio of 6.07 and a quick ratio of 5.28. The stock’s 50 day simple moving average is $3.64 and its 200 day simple moving average is $3.51. The Beauty Health Company has a 1-year low of $1.35 and a 1-year high of $13.90.

Beauty Health (NASDAQ:SKIN) last released its quarterly earnings results on Tuesday, March 12th. The company reported ($0.07) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.04. The business had revenue of $96.80 million for the quarter, compared to analysts’ expectations of $87.22 million. Beauty Health had a negative return on equity of 18.85% and a negative net margin of 25.65%. The company’s revenue was down 1.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.03 EPS. As a group, equities analysts anticipate that The Beauty Health Company will post -0.1 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. Canaccord Genuity Group lifted their price objective on Beauty Health from $3.00 to $4.00 and gave the company a “hold” rating in a research note on Thursday, March 14th. DA Davidson reissued a “buy” rating and issued a $5.00 target price on shares of Beauty Health in a report on Friday, March 15th. Stifel Nicolaus reaffirmed a “hold” rating and set a $4.00 price objective (up from $3.00) on shares of Beauty Health in a research note on Wednesday, March 13th. TD Cowen boosted their target price on Beauty Health from $2.50 to $4.00 and gave the stock a “market perform” rating in a research report on Wednesday, March 13th. Finally, Piper Sandler reiterated an “underweight” rating and set a $3.00 target price (up previously from $2.00) on shares of Beauty Health in a research report on Wednesday, March 13th. Three analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, Beauty Health currently has an average rating of “Hold” and a consensus target price of $6.50.

Beauty Health Company Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.